海納百川》疫苗無用論 佛奇大翻盤（江晃榮） - 海納百川
安東尼·史蒂芬‧佛奇（Anthony Stephen Fauci）是美國免疫學家，曾任美國國家過敏和傳染病研究所所長、白宮冠狀病毒工作組成員及總統首席醫療顧問，曾參與愛滋病和H1N1A型流感以及COVID-19等傳染病的防治研究。佛奇於
Lopi mark this message contains misinformation
｜originally written by Lopi
(1)原文發表於中時 海納百川，屬於讀者投書，投稿人是江晃榮，參考[1]
(2)原文引用佛奇論文摘要，指出《由於這些病毒本身通常無法誘發完整且持久的保護性免疫功能，因此到今天為止沒有疫苗能有效控制病毒，包括已獲正式許可或正實驗中的疫苗在內》(佛奇原文是 Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.） 參考[1][2]
(2)作者江晃榮由此推論《佛奇論文全面否定現有疫苗功效，藥廠賺飽，受害的是受疫苗有用論洗腦的民眾》是為不實解讀。
(3)佛奇的論文主題是"Developing mucosal vaccines for respiratory viruses" 建議將來持續朝不同的方向發展疫苗. 《A next generation of improved vaccines for mucosa-replicating viruses will require advances in understanding on several fronts》
(2)原文引用佛奇論文摘要，指出《由於這些病毒本身通常無法誘發完整且持久的保護性免疫功能，因此到今天為止沒有疫苗能有效控制病毒，包括已獲正式許可或正實驗中的疫苗在內》(佛奇原文是 Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.） 參考[1][2]
(2)作者江晃榮由此推論《佛奇論文全面否定現有疫苗功效，藥廠賺飽，受害的是受疫苗有用論洗腦的民眾》是為不實解讀。
(3)佛奇的論文主題是"Developing mucosal vaccines for respiratory viruses" 建議將來持續朝不同的方向發展疫苗. 《A next generation of improved vaccines for mucosa-replicating viruses will require advances in understanding on several fronts》
References
[1]中時：海納百川》疫苗無用論 佛奇大翻盤（江晃榮）https://www.chinatimes.com/opinion/20230218003317-262110
[2]Developing mucosal vaccines for respiratory viruses https://www.sciencedaily.com/releases/2023/01/230111131529.htm
https://www.chinatimes.com/opinion/20230218003317-262110
Developing mucosal vaccines for respiratory viruses
Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. Researchers now explore the challen
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.